(19)

(11)

EP 3 678 637 A1

(12)

(43) Date of publication: 15.07.2020 Bulletin 2020/29 (21) Application number: 17778342.0 (22) Date of filing: 07.09.2017

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 47/18(2017.01) A61K 9/10(2006.01) A61K 47/10(2017.01) A61K 47/20(2006.01) A61K 31/57(2006.01) (86) International application number: PCT/IB2017/055404 (87) International publication number: WO 2019/048906 (14.03.2019 Gazette 2019/11)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: MA MD (71) Applicant: Teva Pharmaceutical Industries Ltd. 49131 Petah Tikva (IL)	(72) Inventors: SUNDARAMURTHI, Prakash Fort Washington, Pennsylvania 19034 (US) MIJAKOVAC, Ivana 10 000 Zagreb (HR) (74) Representative: Oates, Edward Christopher  Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA London WC1B 5HA (GB)